Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 9, 2016, Pages 1553-1569

  Madsen, Pernille M ^a,b   Clausen, Bettina H ^a   Degn, Matilda ^c   Thyssen, Stine ^a   Kristensen, Lotte K ^a   Svensson, Martina ^d   Ditzel, Nicholas ^e   Finsen, Bente ^a   Deierborg, Tomas ^d   Brambilla, Roberta ^b   Lambertsen, Kate L ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF MIAMI   (United States)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d LUND UNIVERSITY   (Sweden)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

behavior; chemokines; cytokines; macrophages; microglia; neuroprotection; Tumor necrosis factor

Indexed keywords

CXCL1 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; CYTOKINE; MEMBRANE PROTEIN;

ABLATION THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; EXPERIMENTAL CEREBRAL ISCHEMIA; EXPERIMENTAL STROKE; MACROPHAGE; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRESERVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; BRAIN ISCHEMIA; GENETICS; KNOCKOUT MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; SOLUBILITY; STROKE; TIME FACTOR;

ANIMALS; BRAIN ISCHEMIA; CYTOKINES; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NEUROPROTECTION; RNA, MESSENGER; SOLUBILITY; STROKE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84985031110     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X15610339     Document Type: Article

References (95)

1. McCoy MK, and Tansey MG. TNF signaling inhibition in the CNS: implications for normal brain function, and neurodegenerative disease. J Neuroinflammation 2008; 5: 45
2. Probert L. TNF, and its receptors in the CNS: the essential, the desirable, and the deleterious effects. Neuroscience 2015; 302: 2-22
3. Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumour-necrosis factoralpha from cells. Nature 1997; 385: 729-733
4. Grell M, Douni E, Wajant H, et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995; 83: 793-802
5. Grell M, Wajant H, Zimmermann G, et al. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc Natl Acad Sci USA 1998; 95: 570-575
6. Holtmann MH, and Neurath MF. Differential TNF-signaling in chronic inflammatory disorders. Curr Mol Med 2004; 4: 439-444
7. Varfolomeev E, Goncharov T, Fedorova AV, et al. c-IAP1, and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem 2008; 283: 24295-24299
8. Edelblum KL, Goettel JA, Koyama T, et al. TNFR1 promotes tumor necrosis factor-mediated mouse colon epithelial cell survival through RAF activation of NFkappa B. J Biol Chem 2008; 283: 29485-29494
9. Cabal-Hierro L, and Lazo PS. Signal transduction by tumor necrosis factor receptors. Cell Signal 2012; 24: 1297-1305
10. Wajant H. Death receptors. Essays Biochem 2003; 39: 53-71
11. Arnett HA, Mason J, Marino M, et al. TNF alpha promotes proliferation of oligodendrocyte progenitors, and remyelination. Nat Neurosci 2001; 4: 1116-1122
12. Ando T, and Dunn AJ. Mouse tumor necrosis factoralpha increases brain tryptophan concentrations, and norepinephrine metabolism while activating the HPA axis in mice. Neuroimmunomodulation 1999; 6: 319-329
13. Stellwagen D, and Malenka RC. Synaptic scaling mediated by glial TNF-alpha. Nature 2006; 440: 1054-1059
14. Beattie EC, Stellwagen D, Morishita W, et al. Control of synaptic strength by glial TNF alpha. Science 2002; 295: 2282-5
15. Baune BT, Wiede F, Braun A, et al. Cognitive dysfunction in mice deficient for TNF-and its receptors. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1056-1064
16. Golan H, Levav T, Mendelsohn A, et al. Involvement of tumor necrosis factor alpha in hippocampal development, and function. Cereb Cortex 2004; 14: 97-105
17. Quintana A, Giralt M, Rojas S, et al. Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury. J Neurosci Res 2005; 82: 701-716
18. Patel A, Siegel A, and Zalcman SS. Lack of aggression, and anxiolytic-like behavior in TNF receptor (TNF-R1, and TNF-R2) deficient mice. Brain Behav Immun 2010; 24: 1276-1280
19. Ruuls SR, Hoek RM, Ngo VN, et al. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 2001; 15: 533-543
20. Alexopoulou L, Kranidioti K, Xanthoulea S, et al. Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation, and autoimmunity. Eur J Immunol 2006; 36: 2768-2680
21. Brambilla R, Ashbaugh JJ, Magliozzi R, et al. Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis, and promotes axon preservation, and remyelination. Brain 2011; 134: 2736-2754
22. Novrup HG, Bracchi-Ricard V, Ellman DG, et al. Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in mice. J Neuroinflammation 2014; 11: 159
23. Lambertsen KL, Biber K, and Finsen B. Inflammatory cytokines in experimental, and human stroke. J Cereb Blood Flow Metab 2012; 32: 1677-1698
24. Hallenbeck JM. The many faces of tumor necrosis factor in stroke. Nat Med 2002; 8: 1363-1368
25. Sotgiu S, Zanda B, Marchetti B, et al. Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol 2006; 13: 505-513
26. Intiso D, Zarrelli MM, Lagioia G, et al. Tumor necrosis factor alpha serum levels, and inflammatory response in acute ischemic stroke patinets. Neurol Sci 2003; 24: 390-396
27. Mazzotta G, Sarchielli P, Caso V, et al. Different cytokine levels in thrombolysis patients as predictors for clinical outcome. Eur J Neurol 2004; 11: 377-381
28. Zaremba J, and Losy J. The levels of TNF-alpha in cerebrospinal fluid, and serum do not correlate with the counts of the white blood cells in acute phase of ischaemic stroke. Folia Morphol 2001; 60: 91-97
29. Sairanen T, Carpen O, Karjalainen-Lindsberg ML, et al. Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke 2001; 32: 1750-1758
30. Zaremba J, and Losy J. Early TNF-alpha levels correlate with ischaemic stroke severity. Acta Neurol Scand 2001; 104: 288-295
31. Castellanos M, Castillo J, Garcia MM, et al. Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke 2002; 33: 982-987
32. Gu L, Wu G, Long J, et al. The role of TNF-alpha 308G>A polymorphism in the risk for ischemic stroke. Am J Med Sci 2013; 345: 227-233
33. Gu L, Su L, Wu G, et al. Association between TNF-delta 238G/A polymorphisms, and the risk of ischemic stroke. Int J Neurosci 2013; 123: 1-6
34. Cui G, Wang H, Li R, et al. Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke. J Neuroinflammation 2012; 9: 235
35. Gregersen R, Lambertsen K, and Finsen B. Microglia, and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 2000; 20: 53-65
36. Lambertsen KL, Meldgaard M, Ladeby R, et al. A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute, and late focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2005; 25: 119-135
37. Lambertsen KL, Clausen BH, Babcock AA, et al. Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 2009; 29: 1319-1330
38. Clausen BH, Lambertsen KL, Babcock AA, et al. Interleukin-1beta, and tumor necrosis factor-alpha are expressed by different subsets of microglia, and macrophages after ischemic stroke in mice. J Neuroinflammation 2008; 5: 46
39. Lambertsen KL, Clausen BH, Fenger C, et al. Microglia, and macrophages express tumor necrosis factor receptor p75 following middle cerebral artery occlusion in mice. Neuroscience 2007; 144: 934-949
40. Pradillo JM, Romera C, Hurtado O, et al. TNFR1 upregulation mediates tolerance after brain ischemic preconditioning. J Cereb Blood Flow Metab 2005; 25: 193-203
41. Taoufik E, Petit E, Divoux D, et al. TNF receptor I sensitizes neurons to erythropoietin-and VEGF-mediated neuroprotection after ischemic, and excitotoxic injury. Proc Natl Acad Sci USA 2008; 105: 6185-6190
42. Taoufik E, Valable S, Muller GJ, et al. FLIP(L) protects neurons against in vivo ischemia, and in vitro glucose deprivation-induced cell death. J Neurosci 2007; 27: 6633-6646
43. Torres D, Janot L, Quesniaux VF, et al. Membrane tumor necrosis factor confers partial protection to Listeria infection. Am J Pathol 2005; 167: 1677-1687
44. Pasparakis M, Alexopoulou L, Episkopou V, et al. Immune, and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks, and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996; 184: 1397-1411
45. Lambertsen KL, Gramsbergen JB, Sivasaravanaparan M, et al. Genetic KCa3.1-deficiency produces locomotor hyperactivity, and alterations in cerebral monoamine levels. PLoS One 2012; 7: e47744
46. Bach A, Clausen BH, Moller M, et al. A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2, and protects against ischemic brain damage. Proc Natl Acad Sci USA 2012; 109: 3317-3322
47. Clausen B, Degn M, Martin N, et al. Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia. J Neuroinflammation 2014; 11: 203
48. Metz GA, and Whishaw IQ. Cortical, and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore-and hindlimb stepping, placing, and co-ordination. J Neurosci Methods 2002; 115: 169-179
49. Clausen BH, Lambertsen KL, and Finsen B. Glyceraldehyde-3-phosphate dehydrogenase versus toluidine blue as a marker for infarct volume estimation following permanent middle cerebral artery occlusion in mice. Exp Brain Res 2006; 175: 60-67
50. Moller A, Christophersen P, Drejer J, et al. Pharmacological profile, and anti-ischemic properties of the Ca(2+)-channel blocker NS-638. Neurol Res 1995; 17(5): 353-360
51. Lambertsen KL, Gregersen R, Meldgaard M, et al. A role for interferon-gamma in focal cerebral ischemia in mice. J Neuropathol Exp Neurol 2004; 63: 942-955
52. Lin TN, He YY, Wu G, et al. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 1993; 24: 117-121
53. Wirenfeldt M, Dissing-Olesen L, Anne Babcock A, et al. Population control of resident, and immigrant microglia by mitosis, and apoptosis. Am J Pathol 2007; 171: 617-631
54. Lyck L, Kroigard T, and Finsen B. Unbiased cell quantification reveals a continued increase in the number of neocortical neurones during early post-natal development in mice. Eur J Neurosci 2007; 26: 1749-1764
55. Lambertsen KL, Gregersen R, and Finsen B. Microglialmacrophage synthesis of tumor necrosis factor after focal cerebral ischemia in mice is strain dependent. J Cereb Blood Flow Metab 2002; 22: 785-797
56. Lambertsen KL, Ostergaard K, Clausen BH, et al. No effect of ablation of surfactant protein-D on acute cerebral infarction in mice. J Neuroinflammation 2014; 11: 123
57. Taoufik E, Tseveleki V, Chu SY, et al. Transmembrane tumour necrosis factor is neuroprotective, and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB. Brain 2011; 134(Pt 9): 2722-2735
58. Cunningham CL, Martinez-Cerdeno V, and Noctor SC. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci 2013; 33: 4216-4233
59. Golan H, Levav T, and Huleihel M. Distinct expression, and distribution of vesicular proteins in the hippocampus of TNFa-deficient mice during development. Synapse 2004; 53: 6-10
60. Barker V, Middleton G, Davey F, et al. TNFalpha contributes to the death of NGF-dependent neurons during development. Nat Neurosci 2001; 4: 1194-1198
61. Olleros ML, Vesin D, Bisig R, et al. Membrane-bound TNF induces protective immune responses to M. bovis BCG infection: regulation of memTNF, and TNF receptors comparing two memTNF molecules. PLoS One 2012; 7: e31469
62. Chen Z, and Palmer TD. Differential roles of TNFR1, and TNFR2 signaling in adult hippocampal neurogenesis. Brain Behav Immun 2013; 30: 45-53
63. Li Y, Li A, Strait K, et al. Endogenous TNFalpha lowers maximum peak bone mass, and inhibits osteoblastic Smad activation through NF-kappaB. J Bone Miner Res 2007; 22: 646-655
64. Ventre J, Doebber T, Wu M, et al. Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese, and nonobese mice. Diabetes 1997; 46: 1526-1531
65. McAfoose J, Koerner H, and Baune BT. The effects of TNF deficiency on age-related cognitive performance. Psychoneuroendocrinology 2009; 34: 615-619
66. Naude PJ, Dobos N, van Der Meer D, et al. Analysis of cognition, motor performance, and anxiety in young, and aged tumor necrosis factor alpha receptor 1, and 2 deficient mice. Behavioural brain research 2014; 258: 43-51
67. Gimsa U, Kanitz E, Otten W, et al. Tumour necrosis factor receptor deficiency alters anxiety-like behavioural, and neuroendocrine stress responses of mice. Cytokine 2012; 59: 72-78
68. Simen BB, Duman CH, Simen AA, et al. TNFalpha signaling in depression, and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry 2006; 59: 775-785
69. Yamada K, Iida R, Miyamoto Y, et al. Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-alpha gene: implications for emotional behavior. J Neuroimmunol 2000; 111: 131-138
70. Stellwagen D, Beattie EC, Seo JY, et al. Differential regulation of AMPA receptor, and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 2005; 25: 3219-3228
71. Lewitus GM, Pribiag H, Duseja R, et al. An adaptive role of TNFalpha in the regulation of striatal synapses. J Neurosci 2014; 34: 6146-6155
72. Bruce AJ, Boling W, Kindy MS, et al. Altered neuronal, and microglial responses to excitotoxic, and ischemic brain injury in mice lacking TNF receptors. Nat Med 1996; 2: 788-794
73. Gary DS, Bruce-Keller AJ, Kindy MS, et al. Ischemic, and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 1998; 18: 1283-1287
74. Taoufik E, Tseveleki V, Euagelidou M, et al. Positive, and negative implications of tumor necrosis factor neutralization for the pathogenesis of multiple sclerosis. Neurodegenerative Dis 2008; 5: 32-37
75. Dziewulska D, and Mossakowski MJ. Cellular expression of tumor necrosis factor a, and its receptors in human ischemic stroke. Clin Neuropathol 2003; 22: 35-40
76. Lavine SD, Hofman FM, and Zlokovic BV. Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury. J Cereb Blood Flow Metab 1998; 18: 52-58
77. Barone FC, Arvin B, White RF, et al. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 1997; 28: 1233-1244
78. Dawson DA, Martin D, and Hallenbeck JM. Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci Lett 1996; 218: 41-44
79. Pettigrew LC, Kindy MS, Scheff S, et al. Focal cerebral ischemia in the TNFalpha-transgenic rat. J Neuroinflammation 2008; 5: 47
80. Sumbria RK, Boado RJ, and Pardridge WM. Brain protection from stroke with intravenous TNFalpha decoy receptor-Trojan horse fusion protein. J Cereb Blood Flow Metab 2012; 32: 1933-1938
81. Chio CC, Lin JW, Chang MW, et al. Therapeutic evaluation of etanercept in a model of traumatic brain injury. J Neurochem 2010; 115: 921-929
82. Chio CC, Chang CH, Wang CC, et al. Etanercept attenuates traumatic brain injury in rats by reducing early microglial expression of tumor necrosis factor-alpha. BMC Neurosci 2013; 14: 33
83. Perez-Polo JR, Rea HC, Johnson KM, et al. A rodent model of mild traumatic brain blast injury. J Neurosci Res 2015; 93: 549-561
84. Baratz R, Tweedie D, Wang JY, et al. Transiently lowering tumor necrosis factor-alpha synthesis ameliorates neuronal cell loss, and cognitive impairments induced by minimal traumatic brain injury in mice. J Neuroinflammation 2015; 12: 45
85. Tobinick E, Kim NM, Reyzin G, et al. Selective TNF inhibition for chronic stroke, and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs 2012; 26: 1051-1070
86. Fischer R, Wajant H, Kontermann R, et al. Astrocytespecific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor. Glia 2014; 62: 272-283
87. Veroni C, Gabriele L, Canini I, et al. Activation of TNF receptor 2 in microglia promotes induction of antiinflammatory pathways. Mol Cell Neurosci 2010; 45: 234-244
88. Maier O, Fischer R, Agresti C, et al. TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress. Biochem Biophys Res Commun 2013; 440: 336-341
89. Patel JR, Williams JL, Muccigrosso MM, et al. Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation, and differentiation within the adult CNS. Acta Neuropathol 2012; 124: 847-860
90. Clausen BH, Lambertsen KL, Meldgaard M, et al. A quantitative in situ hybridization, and polymerase chain reaction study of microglial-macrophage expression of interleukin-1beta mRNA following permanent middle cerebral artery occlusion in mice. Neuroscience 2005; 132: 879-892
91. Hill JK, Gunion-Rinker L, Kulhanek D, et al. Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain Res 1999; 820: 45-54
92. Liu T, Young PR, McDonnell PC, et al. Cytokineinduced neutrophil chemoattractant mRNA expressed in cerebral ischemia. Neurosci Lett 1993; 164: 125-128
93. Wang X, Ellison JA, Siren AL, et al. Prolonged expression of interferon-inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat. J Neurochem 1998; 71: 1194-1204
94. Wang X, Yue TL, Barone FC, et al. Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. Stroke 1995; 26: 661-665; discussion 665-666
95. Saunders BM, Tran S, Ruuls S, et al. Transmembrane TNF is sufficient to initiate cell migration, and granuloma formation, and provide acute, but not long-term, control of Mycobacterium tuberculosis infection. J Immunol 2005; 174: 4852-4859